Prime Medicine PRME
$3.55 −$0.29 (-7.55%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $3.56 +0.28%
Open$3.70
Prev close$3.84
Day range$3.49 – $3.94
Volume6.13M
Market cap$791.62M
P/E (TTM)–
Dividend yield–
PRME Stock News
Headlines matching Prime Medicine or the PRME ticker, most recent first.
- TD Cowen Maintains Prime Medicine(PRME.US) With Buy Rating
- Chardan Capital Maintains Prime Medicine(PRME.US) With Buy Rating, Maintains Target Price $7
- Analysts Are Bullish on These Healthcare Stocks: Prime Medicine, Inc. (PRME), Edgewise Therapeutics (EWTX) Positive
- Analysts Are Bullish on Top Healthcare Stocks: Arcus Biosciences (RCUS), Prime Medicine, Inc. (PRME) Positive
- Chardan Capital Sticks to Their Buy Rating for Prime Medicine, Inc. (PRME)
- Oppenheimer Remains a Buy on Prime Medicine, Inc. (PRME)
- Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Merck & Company (MRK)
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Cresco Labs (OtherCRLBF), Prime Medicine, Inc. (PRME) and Steris (STE)
- JonesTrading Maintains Prime Medicine(PRME.US) With Buy Rating, Maintains Target Price $5
- Chardan Capital Reaffirms Their Buy Rating on Prime Medicine, Inc. (PRME)
- Chardan Capital Initiates Prime Medicine(PRME.US) With Buy Rating, Announces Target Price $7
- Morgan Stanley Maintains Prime Medicine(PRME.US) With Hold Rating
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR)
- Analysts Offer Insights on Healthcare Companies: Aligos Therapeutics (ALGS), ATyr Pharma (ATYR) and Prime Medicine, Inc. (PRME)
- Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Prime Medicine, Inc. (PRME) and Community Health (CYH)
No comments yet — be the first to weigh in on PRME.
Sign in to join the discussion.